Whence epithelial ovarian carcinoma?

Gynecologic Oncology

Volumn 109, Issue 2, 2008, Pages 161-163

  Boyd, Jeff ^a  

^a MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

CANCER STAGING; CARCINOGENESIS; DYSPLASIA; EDITORIAL; HUMAN; HYPERPLASIA; OVARY CARCINOMA; PRECANCER; PRIORITY JOURNAL; PROGNOSIS;

CARCINOMA; FALLOPIAN TUBE NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, BIOLOGICAL; MUTATION; OVARIAN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 42949091360     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.03.016     Document Type: Editorial

References (25)

1. Jemal A., Siegal R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics. CA Cancer J. Clin. 58 (2008) 71-96
2. Rosenthal A.N., Menon U., and Jacobs I.J. Screening for ovarian cancer. Clin. Obstet. Gynecol. 49 (2006) 433-447
3. Kohn E.C., Azad N., Annunziata C., Dhamoon A.S., and Whiteley G. Proteomics as a tool for biomarker discovery. Dis. Markers 23 (2007) 411-417
4. Visintin I., Feng Z., Longton G., Ward D.C., Alvero A.B., Lai Y., et al. Diagnostic markers for early detection of ovarian cancer. Clin. Cancer Res. 14 (2008) 1065-1072
5. Narod S.A., and Boyd J. Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Curr. Opin. Obstet. Gynecol. 14 (2002) 19-26
6. Radisavljevic S.V. The pathogenesis of ovarian inclusion cysts and cystomas. Obstet. Gynecol. 49 (1977) 424-429
7. Scully R.E. Pathology of ovarian cancer precursors. J. Cell. Biochem., Suppl. 23 (1995) 208-218
8. Auersperg N., Edelson M.I., Mok S.C., Johnson S.W., and Hamilton T.C. The biology of ovarian cancer. Semin. Oncol. 25 (1998) 281-304
9. Dubeau L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?. Gynecol. Oncol. 72 (1999) 437-442
10. Clement P.B., Young R.H., and Scully R.E. Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas. Am. J. Surg. Pathol. 20 (1996) 1067-1080
11. Seidman J.D., Russell P., and Kurman R.J. Surface epithelial tumors of the ovary. In: Kurman R.J. (Ed). Blaustein's pathology of the female genital tract. 5th ed. (2002), Springer, New York 791-904
12. Deligdisch L., Einstein A.J., Guera D., and Gil J. Ovarian dysplasia in epithelial inclusion cysts. A morphometric approach using neural networks. Cancer 76 (1995) 1027-1034
13. Resta L., Russo S., Colucci G.A., and Prat J. Morphologic precursors of ovarian epithelial tumors. Obstet. Gynecol. 82 (1993) 181-186
14. Deligdisch L., Gil J., Kerner H., Wu H.S., Beck D., and Gershoni-Baruch R. Ovarian dysplasia in prophylactic oophorectomy specimens. Cancer 86 (1999) 1544-1550
15. Werness B.A., Afify A.M., Bielat K.L., Eltabbakh G.H., Piver S.M., and Paterson J.M. Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Human Pathol. 30 (1999) 151-157
16. Bell D.A., and Scully R.E. Early de novo ovarian carcinoma. A study of fourteen cases. Cancer 73 (1994) 1859-1864
17. Thomas N.A., Neville P.J., Baxter S.W., and Campbell I.G. Genetic analysis of benign ovarian tumors. Int. J. Cancer 105 (2003) 499-505
18. Werness B.A., Parvatiyar P., Ramus S.J., Whittemore A.S., Garlinghouse-Jones K., Oakley-Girvan I., et al. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. J. Natl. Cancer Inst. 92 (2000) 1088-1091
19. IeM S., and Kurman R.J. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am. J. Pathol. 164 (2004) 1511-1518
20. Bell D.A. Origins and molecular pathology of ovarian cancer. Mod. Path. Suppl. 2 (2005) S19-S32
21. Landen Jr. C.N., Birrer M.J., and Sood A.K. Early events in the pathogenesis of epithelial ovarian cancer. J. Clin. Oncol. 26 (2008) 995-1005
22. Folkins A.K., Jarboe E.A., Saleemuddin A., Lee Y., Callahan M.J., Drapkin R., et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with heterozygous BRCA mutations. Gynecol. Oncol. (2008)
23. Piek J.M., van Diest P.J., Zweemer R.P., Jansen J.W., Poort-Keesom R.J., Menko F.H., et al. Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J. Pathol. 195 (2001) 451-456
24. Piek J.M., Kenemans P., and Verheijen R.H. Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. Am. J. Obstet. Gynecol. 191 (2004) 718-732
25. Lee Y., Miron A., Drapkin R., Nucci M.R., Medeiros F., Saleemuddin A., et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 211 (2007) 26-35